OPPM

Opus Point Partners Management Portfolio holdings

AUM $46.9M
This Quarter Return
+9.12%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$102M
AUM Growth
+$102M
Cap. Flow
+$4.77M
Cap. Flow %
4.69%
Top 10 Hldgs %
47.07%
Holding
64
New
3
Increased
23
Reduced
5
Closed
4

Top Buys

1
BIVV
Bioverativ Inc. Common Stock
BIVV
$631K
2
ACAD icon
Acadia Pharmaceuticals
ACAD
$589K
3
UTHR icon
United Therapeutics
UTHR
$481K
4
SGEN
Seagen Inc. Common Stock
SGEN
$336K
5
RARE icon
Ultragenyx Pharmaceutical
RARE
$306K

Top Sells

1
KITE
Kite Pharma, Inc.
KITE
$613K
2
MYGN icon
Myriad Genetics
MYGN
$527K
3
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
$404K
4
IOVA icon
Iovance Biotherapeutics
IOVA
$220K
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
$192K

Sector Composition

1 Healthcare 78.98%
2 Real Estate 0.38%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALXN
26
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$1.61M 1.44% 11,447 +1,921 +20% +$270K
LABU icon
27
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$647M
$1.37M 1.23% 16,002 – –
LOXO
28
DELISTED
Loxo Oncology, Inc
LOXO
$1.27M 1.14% 13,800 – –
CLVS
29
DELISTED
Clovis Oncology, Inc.
CLVS
$1.24M 1.11% 15,000 – –
KPTI icon
30
Karyopharm Therapeutics
KPTI
$61.7M
$1.1M 0.99% 100,000 – –
PRTK
31
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1M 0.9% 40,000 – –
PCRX icon
32
Pacira BioSciences
PCRX
$1.2B
$939K 0.84% 25,000 – –
AXSM icon
33
Axsome Therapeutics
AXSM
$6.05B
$741K 0.66% 133,500 – –
JUNO
34
DELISTED
Juno Therapeutics, Inc.
JUNO
$660K 0.59% 14,720 -3,250 -18% -$146K
TSRO
35
DELISTED
TESARO, Inc.
TSRO
$646K 0.58% 5,000 – –
ADMS
36
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$635K 0.57% 30,000 – –
RARE icon
37
Ultragenyx Pharmaceutical
RARE
$2.89B
$634K 0.57% 11,899 +5,742 +93% +$306K
BIVV
38
DELISTED
Bioverativ Inc. Common Stock
BIVV
$631K 0.57% +11,056 New +$631K
NBIX icon
39
Neurocrine Biosciences
NBIX
$13.8B
$591K 0.53% 9,644 +4,469 +86% +$274K
ACAD icon
40
Acadia Pharmaceuticals
ACAD
$4.38B
$589K 0.53% +15,639 New +$589K
GRFS icon
41
Grifois
GRFS
$6.78B
$543K 0.49% 24,805 +11,920 +93% +$261K
CRL icon
42
Charles River Laboratories
CRL
$8.04B
$535K 0.48% 4,955 +2,393 +93% +$258K
GILD icon
43
Gilead Sciences
GILD
$140B
$524K 0.47% 6,462 +3,206 +98% +$260K
MDCO
44
DELISTED
Medicines Co
MDCO
$519K 0.47% 14,000 – –
TECH icon
45
Bio-Techne
TECH
$8.5B
$516K 0.46% 4,268 +2,156 +102% +$261K
IQV icon
46
IQVIA
IQV
$32.4B
$515K 0.46% 5,413 +2,492 +85% +$237K
CKPT
47
DELISTED
Checkpoint Therapeutics
CKPT
$507K 0.45% 112,760 -5,000 -4% -$22.5K
UTHR icon
48
United Therapeutics
UTHR
$13.8B
$481K 0.43% +4,108 New +$481K
PGEN icon
49
Precigen
PGEN
$1.34B
$455K 0.41% 23,928 +5,583 +30% +$106K
AKBA icon
50
Akebia Therapeutics
AKBA
$833M
$413K 0.37% 21,009 – –
1
2
3